244 related articles for article (PubMed ID: 35159141)
1. Metabolic Alterations in a
Solana-Manrique C; Sanz FJ; Torregrosa I; Palomino-Schätzlein M; Hernández-Oliver C; Pineda-Lucena A; Paricio N
Cells; 2022 Jan; 11(3):. PubMed ID: 35159141
[TBL] [Abstract][Full Text] [Related]
2. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease.
Solana-Manrique C; Muñoz-Soriano V; Sanz FJ; Paricio N
Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166152. PubMed ID: 33892078
[TBL] [Abstract][Full Text] [Related]
3. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency.
Solana-Manrique C; Sanz FJ; Ripollés E; Bañó MC; Torres J; Muñoz-Soriano V; Paricio N
Free Radic Biol Med; 2020 Oct; 158():137-148. PubMed ID: 32726690
[TBL] [Abstract][Full Text] [Related]
4. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila.
Sanz FJ; Solana-Manrique C; Lilao-Garzón J; Brito-Casillas Y; Muñoz-Descalzo S; Paricio N
FASEB J; 2022 Aug; 36(8):e22432. PubMed ID: 35766235
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.
Sanz FJ; Solana-Manrique C; Muñoz-Soriano V; Calap-Quintana P; Moltó MD; Paricio N
Free Radic Biol Med; 2017 Jul; 108():683-691. PubMed ID: 28455141
[TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson's Disease Treatment.
Sanz FJ; Solana-Manrique C; Torres J; Masiá E; Vicent MJ; Paricio N
Neurotherapeutics; 2021 Oct; 18(4):2565-2578. PubMed ID: 34697772
[TBL] [Abstract][Full Text] [Related]
7. Disease-Modifying Effects of Vincamine Supplementation in
Sanz FJ; Solana-Manrique C; Paricio N
ACS Chem Neurosci; 2023 Jun; 14(12):2294-2301. PubMed ID: 37289979
[TBL] [Abstract][Full Text] [Related]
8. Drosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO.
Hwang S; Song S; Hong YK; Choi G; Suh YS; Han SY; Lee M; Park SH; Lee JH; Lee S; Bang SM; Jeong Y; Chung WJ; Lee IS; Jeong G; Chung J; Cho KS
PLoS Genet; 2013 Apr; 9(4):e1003412. PubMed ID: 23593018
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis.
De Lazzari F; Agostini F; Plotegher N; Sandre M; Greggio E; Megighian A; Bubacco L; Sandrelli F; Whitworth AJ; Bisaglia M
Neurobiol Dis; 2023 Jan; 176():105941. PubMed ID: 36473592
[TBL] [Abstract][Full Text] [Related]
10. Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction.
Park J; Kim SY; Cha GH; Lee SB; Kim S; Chung J
Gene; 2005 Nov; 361():133-9. PubMed ID: 16203113
[TBL] [Abstract][Full Text] [Related]
11. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease.
Meulener M; Whitworth AJ; Armstrong-Gold CE; Rizzu P; Heutink P; Wes PD; Pallanck LJ; Bonini NM
Curr Biol; 2005 Sep; 15(17):1572-7. PubMed ID: 16139213
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
[TBL] [Abstract][Full Text] [Related]
13. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
14. Impaired Taste Associative Memory and Memory Enhancement by Feeding Omija in Parkinson's Disease Fly Model.
Poudel S; Lee Y
Mol Cells; 2018 Jul; 41(7):646-652. PubMed ID: 29936793
[TBL] [Abstract][Full Text] [Related]
15. Lessons from Drosophila models of DJ-1 deficiency.
Moore DJ; Dawson VL; Dawson TM
Sci Aging Knowledge Environ; 2006 Jan; 2006(2):pe2. PubMed ID: 16407572
[TBL] [Abstract][Full Text] [Related]
16. N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson's disease.
Guo T; Zhou L; Xiong M; Xiong J; Huang J; Li Y; Zhang G; Chen G; Wang ZH; Xiao T; Hu D; Bao A; Zhang Z
Aging Cell; 2024 May; 23(5):e14124. PubMed ID: 38380563
[TBL] [Abstract][Full Text] [Related]
17. PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
Lind-Holm Mogensen F; Scafidi A; Poli A; Michelucci A
J Neuroinflammation; 2023 Apr; 20(1):95. PubMed ID: 37072827
[TBL] [Abstract][Full Text] [Related]
18. Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1beta mutants.
Lavara-Culebras E; Muñoz-Soriano V; Gómez-Pastor R; Matallana E; Paricio N
Gene; 2010 Aug; 462(1-2):26-33. PubMed ID: 20423725
[TBL] [Abstract][Full Text] [Related]
19. Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.
Dolgacheva LP; Berezhnov AV; Fedotova EI; Zinchenko VP; Abramov AY
J Bioenerg Biomembr; 2019 Jun; 51(3):175-188. PubMed ID: 31054074
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 Protein and Its Role in the Development of Parkinson's Disease: Studies on Experimental Models.
Buneeva OA; Medvedev AE
Biochemistry (Mosc); 2021 Jun; 86(6):627-640. PubMed ID: 34225587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
